Home / IL-32 / Human IL-32 Antibody

Human IL-32 Antibody

Catalog #: AF3040
18 Citations 1 Review Datasheet / COA / SDS
Catalog # Availability Size / Price Qty
AF3040
AF3040-SP

Select the "Bulk Orders" button to request additional sizes or formulations. 

Detection of IL-32 by Western Blot
28 Images
Product Details
Citations (18)
FAQs
Supplemental Products
Reviews (1)
Summary Data Examples Preparation and Storage Reconstitution Calculator Background Product Datasheets Related Research Areas

Human IL-32 Antibody Summary

Species Reactivity
Human
Specificity
Detects human IL-32 in direct ELISAs and Western blots.
Source
Polyclonal Goat IgG
Purification
Antigen Affinity-purified
Immunogen
E. coli-derived recombinant human IL‑32 alpha
Cys2-Lys131
Accession # NP_001012651
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Applications

Recommended Concentration
Sample
Western Blot
0.1 µg/mL

Recombinant Human IL‑32 alpha

Recombinant Human IL-32 beta

Recombinant Human IL-32 gamma (Catalog # 4690-IL/CF)

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Scientific Data

Western Blot Detection of IL-32 by Western Blot View Larger

Detection of IL-32 by Western Blot IL-32 is stabilized by deubiquitinases. (A) JJN3 cells were stimulated with PR619 (30 μM during normoxia and hypoxia before the sample was harvested at indicated time points. The figure shows representative WB of IL-32 protein levels of n = 3 independent experiments. (B) JJN3 cells were incubated overnight in hypoxia before they were moved to normoxia for 4 h with and without PR619 stimulation. Cells were harvested, and lysates were processed in the presence of a NEM-DUB inhibitor. Ubiqutinylated and nonubiqutinylated 27 kDA IL-32 proteins were assessed by WB. (C) JJN3 cells were stimulated with a panel of DUB inhibitors (see Supplementary Table S1 for concentrations) for 4 h, and IL-32 protein levels were analyzed by WB. Shown here is the representative WB of n = 3 independent experiments. (D) Human primary T cells isolated from healthy blood donors were treated with CHX (5 µg/ml), MG132 (20 µM), and PR619 (30 µM) and harvested at the indicated time points. Shown here is the representative WB from experiments with n = 3 donors. (E) Human primary T cells isolated from healthy blood donors were cultured overnight in hypoxia before IL-32 protein levels were assessed by WB. A representative WB from experiments with three different donors is shown here. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of IL-32 by Western Blot View Larger

Detection of IL-32 by Western Blot IL-32 protein half-life is regulated by the oxygen sensor ADO. (A) JJN-3 cells were transfected with ADO- and nontargeting Ctrl siRNA. After 24 h, the cells were seeded and cultured overnight in normoxia or hypoxia before being treated with 5 μg/ml CHX and the IL-32 CHX chase assay in normoxia and hypoxia. One representative WB of IL-32 and ADO siRNA-treated cells of n = 5 independent experiments is shown. (B) JJN-3 cells were transfected with ADO and nontargeting Ctrl siRNA. After being transfected for 24 h, the cells were cultured overnight in hypoxia before being treated with 5 µg/ml CHX and reoxygenized in normoxic culture conditions. Cells were harvested at indicated time points. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of IL-32 by Western Blot View Larger

Detection of IL-32 by Western Blot TLR-induced NF kappa B signaling promotes IL-32 expression in MM cells. (A) RPMI-8226 cells were stimulated with TLR agonists (for concentrations, see methods) for 4 and 24 hours and IL-32 mRNA expression was assessed by qPCR. The figure shows mean ± SEM of 3 independent experiments. (B) RPMI-8226 cells were stimulated with TLR agonists for 4 and 24 hours and IL-32 protein expression was evaluated by western blot. The figure shows representative western blot of 3 independent experiments. (C) RPMI-8226 cells were harvested at different time-points following LPS stimulation (0.1 µg/mL) and IL-32 mRNA expression was analyzed by qPCR (mean ± SD) and (D) IL-32 protein expression by western blot (E) RPMI-8226 TLR4 WT (mock) and KO cell lines were stimulated with LPS and CpG for 24 hours. Figure shows representative western blot (n=3) of IL-32 protein and qPCR analysis of IL-32 mRNA (mean ± SD, n=1) (F) RPMI-8226 TLR9 WT (mock) and KO cell lines were stimulated with LPS and CpG for 24 hours. The figure shows representative western blot (n=2) of IL-32 protein and qPCR analysis of IL-32 mRNA (mean ± SD, n=1) (G) RPMI-8226 cells were stimulated with LPS (0.1 µg/mL) and NG25 (2 µM) or IKK VII (10 µM) for 4 hours. IL-32 mRNA expression (mean ± SEM, n=3) was assessed by qPCR. (H) RPMI-8226 cells were stimulated with LPS, NG25 and IKK VII (concentrations as above) for 4 hours. The figure shows representative western blot (n=3) of IL-32 protein expression. P-values in (A) and (G) are calculated by one-way ANOVA with Dunnett´s multiple comparison test. *p≤ 0.05, **p ≤ 0.001, ****p ≤ 0.0001. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36875074), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of Human IL-32 by Western Blot View Larger

Detection of Human IL-32 by Western Blot IL-32 is degraded through the ubiquitin-proteasome pathway. (A, B) JJN3 cells were treated with 20 µM MG-132 and harvested at the indicated time points. IL-32 protein levels were analyzed by (A) Western blotting, and (B) IL-32 mRNA was assessed by qPCR using GAPDH as housekeeping gene. The bars show the mean RQ of IL-32 ± SD. (C) Confocal images of JJN3 cells treated for 4 h with 100 nM carfilzomib and stained with IL-32 antibody (green) and Hoechst (blue). (D) JJN3 cells were transfected with HA-ubiquitin plasmid and incubated in hypoxia overnight before the cells were harvested and IL-32 immunoprecipitation was performed. Protein levels of HA-ubiquitin, IL-32, and GAPDH loading control were evaluated on WB. Total lysate and IP samples from the same membrane are shown with different brightness/contrast. (E) JJN3 cells were incubated overnight in hypoxia before they were stimulated with MG-132 for 4 h and harvested for TUBE assay of ubiquitinylated proteins. The presence of IL-32 and ubiquitin protein in TUBE pulldown was assessed by WB. DUB treatment for reversal of polyubiqutinylation was included to validate ubiquitin/TUBE pulldown. Total lysate and TUBE samples from the same membrane are shown with different brightness/contrast. (F) JJN3 cells were stimulated with 2 μM TAK234 before the cells were harvested, and IL-32 levels were analyzed by WB. (A–F) One representative experiment out of three is shown. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of IL-32 by Western Blot View Larger

Detection of IL-32 by Western Blot IL-32 protein half-life is regulated by the oxygen sensor ADO. (A) JJN-3 cells were transfected with ADO- and nontargeting Ctrl siRNA. After 24 h, the cells were seeded and cultured overnight in normoxia or hypoxia before being treated with 5 μg/ml CHX and the IL-32 CHX chase assay in normoxia and hypoxia. One representative WB of IL-32 and ADO siRNA-treated cells of n = 5 independent experiments is shown. (B) JJN-3 cells were transfected with ADO and nontargeting Ctrl siRNA. After being transfected for 24 h, the cells were cultured overnight in hypoxia before being treated with 5 µg/ml CHX and reoxygenized in normoxic culture conditions. Cells were harvested at indicated time points. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of IL-32 by Western Blot View Larger

Detection of IL-32 by Western Blot IL-32 is stabilized by deubiquitinases. (A) JJN3 cells were stimulated with PR619 (30 μM during normoxia and hypoxia before the sample was harvested at indicated time points. The figure shows representative WB of IL-32 protein levels of n = 3 independent experiments. (B) JJN3 cells were incubated overnight in hypoxia before they were moved to normoxia for 4 h with and without PR619 stimulation. Cells were harvested, and lysates were processed in the presence of a NEM-DUB inhibitor. Ubiqutinylated and nonubiqutinylated 27 kDA IL-32 proteins were assessed by WB. (C) JJN3 cells were stimulated with a panel of DUB inhibitors (see Supplementary Table S1 for concentrations) for 4 h, and IL-32 protein levels were analyzed by WB. Shown here is the representative WB of n = 3 independent experiments. (D) Human primary T cells isolated from healthy blood donors were treated with CHX (5 µg/ml), MG132 (20 µM), and PR619 (30 µM) and harvested at the indicated time points. Shown here is the representative WB from experiments with n = 3 donors. (E) Human primary T cells isolated from healthy blood donors were cultured overnight in hypoxia before IL-32 protein levels were assessed by WB. A representative WB from experiments with three different donors is shown here. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of Human IL-32 by Western Blot View Larger

Detection of Human IL-32 by Western Blot IL-32 is degraded through the ubiquitin-proteasome pathway. (A, B) JJN3 cells were treated with 20 µM MG-132 and harvested at the indicated time points. IL-32 protein levels were analyzed by (A) Western blotting, and (B) IL-32 mRNA was assessed by qPCR using GAPDH as housekeeping gene. The bars show the mean RQ of IL-32 ± SD. (C) Confocal images of JJN3 cells treated for 4 h with 100 nM carfilzomib and stained with IL-32 antibody (green) and Hoechst (blue). (D) JJN3 cells were transfected with HA-ubiquitin plasmid and incubated in hypoxia overnight before the cells were harvested and IL-32 immunoprecipitation was performed. Protein levels of HA-ubiquitin, IL-32, and GAPDH loading control were evaluated on WB. Total lysate and IP samples from the same membrane are shown with different brightness/contrast. (E) JJN3 cells were incubated overnight in hypoxia before they were stimulated with MG-132 for 4 h and harvested for TUBE assay of ubiquitinylated proteins. The presence of IL-32 and ubiquitin protein in TUBE pulldown was assessed by WB. DUB treatment for reversal of polyubiqutinylation was included to validate ubiquitin/TUBE pulldown. Total lysate and TUBE samples from the same membrane are shown with different brightness/contrast. (F) JJN3 cells were stimulated with 2 μM TAK234 before the cells were harvested, and IL-32 levels were analyzed by WB. (A–F) One representative experiment out of three is shown. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of Human IL-32 by Western Blot View Larger

Detection of Human IL-32 by Western Blot IL-32 is degraded through the ubiquitin-proteasome pathway. (A, B) JJN3 cells were treated with 20 µM MG-132 and harvested at the indicated time points. IL-32 protein levels were analyzed by (A) Western blotting, and (B) IL-32 mRNA was assessed by qPCR using GAPDH as housekeeping gene. The bars show the mean RQ of IL-32 ± SD. (C) Confocal images of JJN3 cells treated for 4 h with 100 nM carfilzomib and stained with IL-32 antibody (green) and Hoechst (blue). (D) JJN3 cells were transfected with HA-ubiquitin plasmid and incubated in hypoxia overnight before the cells were harvested and IL-32 immunoprecipitation was performed. Protein levels of HA-ubiquitin, IL-32, and GAPDH loading control were evaluated on WB. Total lysate and IP samples from the same membrane are shown with different brightness/contrast. (E) JJN3 cells were incubated overnight in hypoxia before they were stimulated with MG-132 for 4 h and harvested for TUBE assay of ubiquitinylated proteins. The presence of IL-32 and ubiquitin protein in TUBE pulldown was assessed by WB. DUB treatment for reversal of polyubiqutinylation was included to validate ubiquitin/TUBE pulldown. Total lysate and TUBE samples from the same membrane are shown with different brightness/contrast. (F) JJN3 cells were stimulated with 2 μM TAK234 before the cells were harvested, and IL-32 levels were analyzed by WB. (A–F) One representative experiment out of three is shown. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of IL-32 by Western Blot View Larger

Detection of IL-32 by Western Blot IL-32 is stabilized by deubiquitinases. (A) JJN3 cells were stimulated with PR619 (30 μM during normoxia and hypoxia before the sample was harvested at indicated time points. The figure shows representative WB of IL-32 protein levels of n = 3 independent experiments. (B) JJN3 cells were incubated overnight in hypoxia before they were moved to normoxia for 4 h with and without PR619 stimulation. Cells were harvested, and lysates were processed in the presence of a NEM-DUB inhibitor. Ubiqutinylated and nonubiqutinylated 27 kDA IL-32 proteins were assessed by WB. (C) JJN3 cells were stimulated with a panel of DUB inhibitors (see Supplementary Table S1 for concentrations) for 4 h, and IL-32 protein levels were analyzed by WB. Shown here is the representative WB of n = 3 independent experiments. (D) Human primary T cells isolated from healthy blood donors were treated with CHX (5 µg/ml), MG132 (20 µM), and PR619 (30 µM) and harvested at the indicated time points. Shown here is the representative WB from experiments with n = 3 donors. (E) Human primary T cells isolated from healthy blood donors were cultured overnight in hypoxia before IL-32 protein levels were assessed by WB. A representative WB from experiments with three different donors is shown here. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of IL-32 by Western Blot View Larger

Detection of IL-32 by Western Blot TLR-induced NF kappa B signaling promotes IL-32 expression in MM cells. (A) RPMI-8226 cells were stimulated with TLR agonists (for concentrations, see methods) for 4 and 24 hours and IL-32 mRNA expression was assessed by qPCR. The figure shows mean ± SEM of 3 independent experiments. (B) RPMI-8226 cells were stimulated with TLR agonists for 4 and 24 hours and IL-32 protein expression was evaluated by western blot. The figure shows representative western blot of 3 independent experiments. (C) RPMI-8226 cells were harvested at different time-points following LPS stimulation (0.1 µg/mL) and IL-32 mRNA expression was analyzed by qPCR (mean ± SD) and (D) IL-32 protein expression by western blot (E) RPMI-8226 TLR4 WT (mock) and KO cell lines were stimulated with LPS and CpG for 24 hours. Figure shows representative western blot (n=3) of IL-32 protein and qPCR analysis of IL-32 mRNA (mean ± SD, n=1) (F) RPMI-8226 TLR9 WT (mock) and KO cell lines were stimulated with LPS and CpG for 24 hours. The figure shows representative western blot (n=2) of IL-32 protein and qPCR analysis of IL-32 mRNA (mean ± SD, n=1) (G) RPMI-8226 cells were stimulated with LPS (0.1 µg/mL) and NG25 (2 µM) or IKK VII (10 µM) for 4 hours. IL-32 mRNA expression (mean ± SEM, n=3) was assessed by qPCR. (H) RPMI-8226 cells were stimulated with LPS, NG25 and IKK VII (concentrations as above) for 4 hours. The figure shows representative western blot (n=3) of IL-32 protein expression. P-values in (A) and (G) are calculated by one-way ANOVA with Dunnett´s multiple comparison test. *p≤ 0.05, **p ≤ 0.001, ****p ≤ 0.0001. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36875074), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of IL-32 by Western Blot View Larger

Detection of IL-32 by Western Blot IL-32 has a high protein turnover. (A) JJN-3 cells were treated with CHX and harvested at the indicated time points. IL-32 protein levels were analyzed by WB. (B) Kinetics of IL-32 degradation in JJN3- cells. IL-32 protein signal intensity was quantified and normalized to loading control in n = 6 CHX chase experiments. The mean ±SEM is shown here. (C) JJN-3 cells were treated with 5 μg/ml CHX and 20 μM MG132 alone and in combination and harvested at the indicated time points. The figure shows one representative WB from n = 3 independent experiments. (D) Signal intensities of IL-32 and beta -actin were quantified from n = 3 independent experiments performed as in (C), and the values from treated samples at each time point were normalized relative to the control sample. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of IL-32 by Western Blot View Larger

Detection of IL-32 by Western Blot TLR-induced NF kappa B signaling promotes IL-32 expression in MM cells. (A) RPMI-8226 cells were stimulated with TLR agonists (for concentrations, see methods) for 4 and 24 hours and IL-32 mRNA expression was assessed by qPCR. The figure shows mean ± SEM of 3 independent experiments. (B) RPMI-8226 cells were stimulated with TLR agonists for 4 and 24 hours and IL-32 protein expression was evaluated by western blot. The figure shows representative western blot of 3 independent experiments. (C) RPMI-8226 cells were harvested at different time-points following LPS stimulation (0.1 µg/mL) and IL-32 mRNA expression was analyzed by qPCR (mean ± SD) and (D) IL-32 protein expression by western blot (E) RPMI-8226 TLR4 WT (mock) and KO cell lines were stimulated with LPS and CpG for 24 hours. Figure shows representative western blot (n=3) of IL-32 protein and qPCR analysis of IL-32 mRNA (mean ± SD, n=1) (F) RPMI-8226 TLR9 WT (mock) and KO cell lines were stimulated with LPS and CpG for 24 hours. The figure shows representative western blot (n=2) of IL-32 protein and qPCR analysis of IL-32 mRNA (mean ± SD, n=1) (G) RPMI-8226 cells were stimulated with LPS (0.1 µg/mL) and NG25 (2 µM) or IKK VII (10 µM) for 4 hours. IL-32 mRNA expression (mean ± SEM, n=3) was assessed by qPCR. (H) RPMI-8226 cells were stimulated with LPS, NG25 and IKK VII (concentrations as above) for 4 hours. The figure shows representative western blot (n=3) of IL-32 protein expression. P-values in (A) and (G) are calculated by one-way ANOVA with Dunnett´s multiple comparison test. *p≤ 0.05, **p ≤ 0.001, ****p ≤ 0.0001. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36875074), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of IL-32 by Western Blot View Larger

Detection of IL-32 by Western Blot TLR-induced NF kappa B signaling promotes IL-32 expression in MM cells. (A) RPMI-8226 cells were stimulated with TLR agonists (for concentrations, see methods) for 4 and 24 hours and IL-32 mRNA expression was assessed by qPCR. The figure shows mean ± SEM of 3 independent experiments. (B) RPMI-8226 cells were stimulated with TLR agonists for 4 and 24 hours and IL-32 protein expression was evaluated by western blot. The figure shows representative western blot of 3 independent experiments. (C) RPMI-8226 cells were harvested at different time-points following LPS stimulation (0.1 µg/mL) and IL-32 mRNA expression was analyzed by qPCR (mean ± SD) and (D) IL-32 protein expression by western blot (E) RPMI-8226 TLR4 WT (mock) and KO cell lines were stimulated with LPS and CpG for 24 hours. Figure shows representative western blot (n=3) of IL-32 protein and qPCR analysis of IL-32 mRNA (mean ± SD, n=1) (F) RPMI-8226 TLR9 WT (mock) and KO cell lines were stimulated with LPS and CpG for 24 hours. The figure shows representative western blot (n=2) of IL-32 protein and qPCR analysis of IL-32 mRNA (mean ± SD, n=1) (G) RPMI-8226 cells were stimulated with LPS (0.1 µg/mL) and NG25 (2 µM) or IKK VII (10 µM) for 4 hours. IL-32 mRNA expression (mean ± SEM, n=3) was assessed by qPCR. (H) RPMI-8226 cells were stimulated with LPS, NG25 and IKK VII (concentrations as above) for 4 hours. The figure shows representative western blot (n=3) of IL-32 protein expression. P-values in (A) and (G) are calculated by one-way ANOVA with Dunnett´s multiple comparison test. *p≤ 0.05, **p ≤ 0.001, ****p ≤ 0.0001. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36875074), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of IL-32 by Western Blot View Larger

Detection of IL-32 by Western Blot IL-32 is stabilized by deubiquitinases. (A) JJN3 cells were stimulated with PR619 (30 μM during normoxia and hypoxia before the sample was harvested at indicated time points. The figure shows representative WB of IL-32 protein levels of n = 3 independent experiments. (B) JJN3 cells were incubated overnight in hypoxia before they were moved to normoxia for 4 h with and without PR619 stimulation. Cells were harvested, and lysates were processed in the presence of a NEM-DUB inhibitor. Ubiqutinylated and nonubiqutinylated 27 kDA IL-32 proteins were assessed by WB. (C) JJN3 cells were stimulated with a panel of DUB inhibitors (see Supplementary Table S1 for concentrations) for 4 h, and IL-32 protein levels were analyzed by WB. Shown here is the representative WB of n = 3 independent experiments. (D) Human primary T cells isolated from healthy blood donors were treated with CHX (5 µg/ml), MG132 (20 µM), and PR619 (30 µM) and harvested at the indicated time points. Shown here is the representative WB from experiments with n = 3 donors. (E) Human primary T cells isolated from healthy blood donors were cultured overnight in hypoxia before IL-32 protein levels were assessed by WB. A representative WB from experiments with three different donors is shown here. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of IL-32 by Western Blot View Larger

Detection of IL-32 by Western Blot IL-32 has a high protein turnover. (A) JJN-3 cells were treated with CHX and harvested at the indicated time points. IL-32 protein levels were analyzed by WB. (B) Kinetics of IL-32 degradation in JJN3- cells. IL-32 protein signal intensity was quantified and normalized to loading control in n = 6 CHX chase experiments. The mean ±SEM is shown here. (C) JJN-3 cells were treated with 5 μg/ml CHX and 20 μM MG132 alone and in combination and harvested at the indicated time points. The figure shows one representative WB from n = 3 independent experiments. (D) Signal intensities of IL-32 and beta -actin were quantified from n = 3 independent experiments performed as in (C), and the values from treated samples at each time point were normalized relative to the control sample. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of IL-32 by Western Blot View Larger

Detection of IL-32 by Western Blot IL-32 protein half-life is regulated by the oxygen sensor ADO. (A) JJN-3 cells were transfected with ADO- and nontargeting Ctrl siRNA. After 24 h, the cells were seeded and cultured overnight in normoxia or hypoxia before being treated with 5 μg/ml CHX and the IL-32 CHX chase assay in normoxia and hypoxia. One representative WB of IL-32 and ADO siRNA-treated cells of n = 5 independent experiments is shown. (B) JJN-3 cells were transfected with ADO and nontargeting Ctrl siRNA. After being transfected for 24 h, the cells were cultured overnight in hypoxia before being treated with 5 µg/ml CHX and reoxygenized in normoxic culture conditions. Cells were harvested at indicated time points. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of IL-32 by Western Blot View Larger

Detection of IL-32 by Western Blot IL-32 is stabilized by deubiquitinases. (A) JJN3 cells were stimulated with PR619 (30 μM during normoxia and hypoxia before the sample was harvested at indicated time points. The figure shows representative WB of IL-32 protein levels of n = 3 independent experiments. (B) JJN3 cells were incubated overnight in hypoxia before they were moved to normoxia for 4 h with and without PR619 stimulation. Cells were harvested, and lysates were processed in the presence of a NEM-DUB inhibitor. Ubiqutinylated and nonubiqutinylated 27 kDA IL-32 proteins were assessed by WB. (C) JJN3 cells were stimulated with a panel of DUB inhibitors (see Supplementary Table S1 for concentrations) for 4 h, and IL-32 protein levels were analyzed by WB. Shown here is the representative WB of n = 3 independent experiments. (D) Human primary T cells isolated from healthy blood donors were treated with CHX (5 µg/ml), MG132 (20 µM), and PR619 (30 µM) and harvested at the indicated time points. Shown here is the representative WB from experiments with n = 3 donors. (E) Human primary T cells isolated from healthy blood donors were cultured overnight in hypoxia before IL-32 protein levels were assessed by WB. A representative WB from experiments with three different donors is shown here. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of IL-32 by Western Blot View Larger

Detection of IL-32 by Western Blot IL-32 has a high protein turnover. (A) JJN-3 cells were treated with CHX and harvested at the indicated time points. IL-32 protein levels were analyzed by WB. (B) Kinetics of IL-32 degradation in JJN3- cells. IL-32 protein signal intensity was quantified and normalized to loading control in n = 6 CHX chase experiments. The mean ±SEM is shown here. (C) JJN-3 cells were treated with 5 μg/ml CHX and 20 μM MG132 alone and in combination and harvested at the indicated time points. The figure shows one representative WB from n = 3 independent experiments. (D) Signal intensities of IL-32 and beta -actin were quantified from n = 3 independent experiments performed as in (C), and the values from treated samples at each time point were normalized relative to the control sample. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of Human IL-32 by Western Blot View Larger

Detection of Human IL-32 by Western Blot IL-32 is degraded through the ubiquitin-proteasome pathway. (A, B) JJN3 cells were treated with 20 µM MG-132 and harvested at the indicated time points. IL-32 protein levels were analyzed by (A) Western blotting, and (B) IL-32 mRNA was assessed by qPCR using GAPDH as housekeeping gene. The bars show the mean RQ of IL-32 ± SD. (C) Confocal images of JJN3 cells treated for 4 h with 100 nM carfilzomib and stained with IL-32 antibody (green) and Hoechst (blue). (D) JJN3 cells were transfected with HA-ubiquitin plasmid and incubated in hypoxia overnight before the cells were harvested and IL-32 immunoprecipitation was performed. Protein levels of HA-ubiquitin, IL-32, and GAPDH loading control were evaluated on WB. Total lysate and IP samples from the same membrane are shown with different brightness/contrast. (E) JJN3 cells were incubated overnight in hypoxia before they were stimulated with MG-132 for 4 h and harvested for TUBE assay of ubiquitinylated proteins. The presence of IL-32 and ubiquitin protein in TUBE pulldown was assessed by WB. DUB treatment for reversal of polyubiqutinylation was included to validate ubiquitin/TUBE pulldown. Total lysate and TUBE samples from the same membrane are shown with different brightness/contrast. (F) JJN3 cells were stimulated with 2 μM TAK234 before the cells were harvested, and IL-32 levels were analyzed by WB. (A–F) One representative experiment out of three is shown. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of IL-32 by Western Blot View Larger

Detection of IL-32 by Western Blot IL-32 has a high protein turnover. (A) JJN-3 cells were treated with CHX and harvested at the indicated time points. IL-32 protein levels were analyzed by WB. (B) Kinetics of IL-32 degradation in JJN3- cells. IL-32 protein signal intensity was quantified and normalized to loading control in n = 6 CHX chase experiments. The mean ±SEM is shown here. (C) JJN-3 cells were treated with 5 μg/ml CHX and 20 μM MG132 alone and in combination and harvested at the indicated time points. The figure shows one representative WB from n = 3 independent experiments. (D) Signal intensities of IL-32 and beta -actin were quantified from n = 3 independent experiments performed as in (C), and the values from treated samples at each time point were normalized relative to the control sample. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of Human IL-32 by Western Blot View Larger

Detection of Human IL-32 by Western Blot IL-32 is degraded through the ubiquitin-proteasome pathway. (A, B) JJN3 cells were treated with 20 µM MG-132 and harvested at the indicated time points. IL-32 protein levels were analyzed by (A) Western blotting, and (B) IL-32 mRNA was assessed by qPCR using GAPDH as housekeeping gene. The bars show the mean RQ of IL-32 ± SD. (C) Confocal images of JJN3 cells treated for 4 h with 100 nM carfilzomib and stained with IL-32 antibody (green) and Hoechst (blue). (D) JJN3 cells were transfected with HA-ubiquitin plasmid and incubated in hypoxia overnight before the cells were harvested and IL-32 immunoprecipitation was performed. Protein levels of HA-ubiquitin, IL-32, and GAPDH loading control were evaluated on WB. Total lysate and IP samples from the same membrane are shown with different brightness/contrast. (E) JJN3 cells were incubated overnight in hypoxia before they were stimulated with MG-132 for 4 h and harvested for TUBE assay of ubiquitinylated proteins. The presence of IL-32 and ubiquitin protein in TUBE pulldown was assessed by WB. DUB treatment for reversal of polyubiqutinylation was included to validate ubiquitin/TUBE pulldown. Total lysate and TUBE samples from the same membrane are shown with different brightness/contrast. (F) JJN3 cells were stimulated with 2 μM TAK234 before the cells were harvested, and IL-32 levels were analyzed by WB. (A–F) One representative experiment out of three is shown. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of IL-32 by Western Blot View Larger

Detection of IL-32 by Western Blot TLR-induced NF kappa B signaling promotes IL-32 expression in MM cells. (A) RPMI-8226 cells were stimulated with TLR agonists (for concentrations, see methods) for 4 and 24 hours and IL-32 mRNA expression was assessed by qPCR. The figure shows mean ± SEM of 3 independent experiments. (B) RPMI-8226 cells were stimulated with TLR agonists for 4 and 24 hours and IL-32 protein expression was evaluated by western blot. The figure shows representative western blot of 3 independent experiments. (C) RPMI-8226 cells were harvested at different time-points following LPS stimulation (0.1 µg/mL) and IL-32 mRNA expression was analyzed by qPCR (mean ± SD) and (D) IL-32 protein expression by western blot (E) RPMI-8226 TLR4 WT (mock) and KO cell lines were stimulated with LPS and CpG for 24 hours. Figure shows representative western blot (n=3) of IL-32 protein and qPCR analysis of IL-32 mRNA (mean ± SD, n=1) (F) RPMI-8226 TLR9 WT (mock) and KO cell lines were stimulated with LPS and CpG for 24 hours. The figure shows representative western blot (n=2) of IL-32 protein and qPCR analysis of IL-32 mRNA (mean ± SD, n=1) (G) RPMI-8226 cells were stimulated with LPS (0.1 µg/mL) and NG25 (2 µM) or IKK VII (10 µM) for 4 hours. IL-32 mRNA expression (mean ± SEM, n=3) was assessed by qPCR. (H) RPMI-8226 cells were stimulated with LPS, NG25 and IKK VII (concentrations as above) for 4 hours. The figure shows representative western blot (n=3) of IL-32 protein expression. P-values in (A) and (G) are calculated by one-way ANOVA with Dunnett´s multiple comparison test. *p≤ 0.05, **p ≤ 0.001, ****p ≤ 0.0001. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36875074), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of Human IL-32 by Western Blot View Larger

Detection of Human IL-32 by Western Blot IL-32 is degraded through the ubiquitin-proteasome pathway. (A, B) JJN3 cells were treated with 20 µM MG-132 and harvested at the indicated time points. IL-32 protein levels were analyzed by (A) Western blotting, and (B) IL-32 mRNA was assessed by qPCR using GAPDH as housekeeping gene. The bars show the mean RQ of IL-32 ± SD. (C) Confocal images of JJN3 cells treated for 4 h with 100 nM carfilzomib and stained with IL-32 antibody (green) and Hoechst (blue). (D) JJN3 cells were transfected with HA-ubiquitin plasmid and incubated in hypoxia overnight before the cells were harvested and IL-32 immunoprecipitation was performed. Protein levels of HA-ubiquitin, IL-32, and GAPDH loading control were evaluated on WB. Total lysate and IP samples from the same membrane are shown with different brightness/contrast. (E) JJN3 cells were incubated overnight in hypoxia before they were stimulated with MG-132 for 4 h and harvested for TUBE assay of ubiquitinylated proteins. The presence of IL-32 and ubiquitin protein in TUBE pulldown was assessed by WB. DUB treatment for reversal of polyubiqutinylation was included to validate ubiquitin/TUBE pulldown. Total lysate and TUBE samples from the same membrane are shown with different brightness/contrast. (F) JJN3 cells were stimulated with 2 μM TAK234 before the cells were harvested, and IL-32 levels were analyzed by WB. (A–F) One representative experiment out of three is shown. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of IL-32 by Western Blot View Larger

Detection of IL-32 by Western Blot IL-32 is stabilized by deubiquitinases. (A) JJN3 cells were stimulated with PR619 (30 μM during normoxia and hypoxia before the sample was harvested at indicated time points. The figure shows representative WB of IL-32 protein levels of n = 3 independent experiments. (B) JJN3 cells were incubated overnight in hypoxia before they were moved to normoxia for 4 h with and without PR619 stimulation. Cells were harvested, and lysates were processed in the presence of a NEM-DUB inhibitor. Ubiqutinylated and nonubiqutinylated 27 kDA IL-32 proteins were assessed by WB. (C) JJN3 cells were stimulated with a panel of DUB inhibitors (see Supplementary Table S1 for concentrations) for 4 h, and IL-32 protein levels were analyzed by WB. Shown here is the representative WB of n = 3 independent experiments. (D) Human primary T cells isolated from healthy blood donors were treated with CHX (5 µg/ml), MG132 (20 µM), and PR619 (30 µM) and harvested at the indicated time points. Shown here is the representative WB from experiments with n = 3 donors. (E) Human primary T cells isolated from healthy blood donors were cultured overnight in hypoxia before IL-32 protein levels were assessed by WB. A representative WB from experiments with three different donors is shown here. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of IL-32 by Western Blot View Larger

Detection of IL-32 by Western Blot IL-32 protein half-life is regulated by the oxygen sensor ADO. (A) JJN-3 cells were transfected with ADO- and nontargeting Ctrl siRNA. After 24 h, the cells were seeded and cultured overnight in normoxia or hypoxia before being treated with 5 μg/ml CHX and the IL-32 CHX chase assay in normoxia and hypoxia. One representative WB of IL-32 and ADO siRNA-treated cells of n = 5 independent experiments is shown. (B) JJN-3 cells were transfected with ADO and nontargeting Ctrl siRNA. After being transfected for 24 h, the cells were cultured overnight in hypoxia before being treated with 5 µg/ml CHX and reoxygenized in normoxic culture conditions. Cells were harvested at indicated time points. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of IL-32 by Western Blot View Larger

Detection of IL-32 by Western Blot TLR-induced NF kappa B signaling promotes IL-32 expression in MM cells. (A) RPMI-8226 cells were stimulated with TLR agonists (for concentrations, see methods) for 4 and 24 hours and IL-32 mRNA expression was assessed by qPCR. The figure shows mean ± SEM of 3 independent experiments. (B) RPMI-8226 cells were stimulated with TLR agonists for 4 and 24 hours and IL-32 protein expression was evaluated by western blot. The figure shows representative western blot of 3 independent experiments. (C) RPMI-8226 cells were harvested at different time-points following LPS stimulation (0.1 µg/mL) and IL-32 mRNA expression was analyzed by qPCR (mean ± SD) and (D) IL-32 protein expression by western blot (E) RPMI-8226 TLR4 WT (mock) and KO cell lines were stimulated with LPS and CpG for 24 hours. Figure shows representative western blot (n=3) of IL-32 protein and qPCR analysis of IL-32 mRNA (mean ± SD, n=1) (F) RPMI-8226 TLR9 WT (mock) and KO cell lines were stimulated with LPS and CpG for 24 hours. The figure shows representative western blot (n=2) of IL-32 protein and qPCR analysis of IL-32 mRNA (mean ± SD, n=1) (G) RPMI-8226 cells were stimulated with LPS (0.1 µg/mL) and NG25 (2 µM) or IKK VII (10 µM) for 4 hours. IL-32 mRNA expression (mean ± SEM, n=3) was assessed by qPCR. (H) RPMI-8226 cells were stimulated with LPS, NG25 and IKK VII (concentrations as above) for 4 hours. The figure shows representative western blot (n=3) of IL-32 protein expression. P-values in (A) and (G) are calculated by one-way ANOVA with Dunnett´s multiple comparison test. *p≤ 0.05, **p ≤ 0.001, ****p ≤ 0.0001. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/36875074), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of IL-32 by Western Blot View Larger

Detection of IL-32 by Western Blot IL-32 is stabilized by deubiquitinases. (A) JJN3 cells were stimulated with PR619 (30 μM during normoxia and hypoxia before the sample was harvested at indicated time points. The figure shows representative WB of IL-32 protein levels of n = 3 independent experiments. (B) JJN3 cells were incubated overnight in hypoxia before they were moved to normoxia for 4 h with and without PR619 stimulation. Cells were harvested, and lysates were processed in the presence of a NEM-DUB inhibitor. Ubiqutinylated and nonubiqutinylated 27 kDA IL-32 proteins were assessed by WB. (C) JJN3 cells were stimulated with a panel of DUB inhibitors (see Supplementary Table S1 for concentrations) for 4 h, and IL-32 protein levels were analyzed by WB. Shown here is the representative WB of n = 3 independent experiments. (D) Human primary T cells isolated from healthy blood donors were treated with CHX (5 µg/ml), MG132 (20 µM), and PR619 (30 µM) and harvested at the indicated time points. Shown here is the representative WB from experiments with n = 3 donors. (E) Human primary T cells isolated from healthy blood donors were cultured overnight in hypoxia before IL-32 protein levels were assessed by WB. A representative WB from experiments with three different donors is shown here. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.

Western Blot Detection of IL-32 by Western Blot View Larger

Detection of IL-32 by Western Blot IL-32 is stabilized by deubiquitinases. (A) JJN3 cells were stimulated with PR619 (30 μM during normoxia and hypoxia before the sample was harvested at indicated time points. The figure shows representative WB of IL-32 protein levels of n = 3 independent experiments. (B) JJN3 cells were incubated overnight in hypoxia before they were moved to normoxia for 4 h with and without PR619 stimulation. Cells were harvested, and lysates were processed in the presence of a NEM-DUB inhibitor. Ubiqutinylated and nonubiqutinylated 27 kDA IL-32 proteins were assessed by WB. (C) JJN3 cells were stimulated with a panel of DUB inhibitors (see Supplementary Table S1 for concentrations) for 4 h, and IL-32 protein levels were analyzed by WB. Shown here is the representative WB of n = 3 independent experiments. (D) Human primary T cells isolated from healthy blood donors were treated with CHX (5 µg/ml), MG132 (20 µM), and PR619 (30 µM) and harvested at the indicated time points. Shown here is the representative WB from experiments with n = 3 donors. (E) Human primary T cells isolated from healthy blood donors were cultured overnight in hypoxia before IL-32 protein levels were assessed by WB. A representative WB from experiments with three different donors is shown here. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/37313466), licensed under a CC-BY license. Not internally tested by R&D Systems.

Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Preparation and Storage

Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS.
Loading...
Shipping
Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: IL-32

Interleukin 32 (IL-32) is an N-glycosylated cytokine that is upregulated by inflammatory stimulation in monocytes, NK cells, epithelial cells, and pancreatic myofibroblasts (1-5). It cooperates with these stimuli to promote the expression of other proinflammatory molecules such as TNF-alpha, IL-6, IL-1 beta, IL-1 alpha, and CXCL8/IL‑8 (5-7). The longest of several IL-32 splicing variants is the 20-25 kDa gamma isoform which is also known as natural killer cell transcript 4 (NK4) (8, 9). The alpha isoform (IL-32 alpha ) lacks a portion of the putative signal peptide as well as 57 aa from the C-terminal region. IL-32 alpha is less potent than IL-32 beta, gamma, or δ at inducing the expression of proinflammatory molecules in peripheral blood mononuclear cells (PBMC) (8, 10). Neutrophil-derived Proteinase 3 (PR3) cleaves IL-32 alpha between Thr57 and Val58, a cleavage site that is retained in other IL-32 isoforms (11). The N-terminal fragment of PR3-cleaved IL-32 alpha shows increased potency at inducing CXCL2/MIP-2 and CXCL8 expression in PBMC relative to uncleaved IL-32 alpha (11, 12). IL-32 is highly expressed by colonic epithelial cells in inflammatory bowel disease and Crohn’s disease, rheumatoid arthritis synovium, and ductal epithelial cells in chronic pancreatitis and pancreatic cancer (5, 13-15). IL-32 inhibits HIV-1 replication in vitro, and it is elevated in the serum of HIV-1 patients (16, 17).

References
  1. Netea, M.G. et al. (2006) PloS Med. 3:e277.
  2. Nold-Petry, C.A. et al. (2009) Proc. Natl. Acad. Sci. USA 106:3883.
  3. Li, W. et al. (2009) Eur. J. Immunol. 39:1019.
  4. Nishida, A. et al. (2008) Am. J. Physiol. Gastrointest. Liver Physiol. 294:G831.
  5. Shoda, H. et al. (2006) Arthritis Res. Ther. 8:R166.
  6. Netea, M.G. et al. (2005) Proc. Natl. Acad. Sci. USA 102:16309.
  7. Hong, J. et al. (2010) Cytokine 49:171.
  8. Kim, S-H. et al. (2005) Immunity 22:131.
  9. Dahl, C.A. et al. (1992) J. Immunol. 148:597.
  10. Choi, J-D. et al. (2009) Immunology 126:535.
  11. Novick, D. et al. (2006) Proc. Natl. Acad. Sci. USA 103:3316.
  12. Kim, S. et al. (2008) BMB Rep. 41:814.
  13. Shioya, M. et al. (2007) Clin. Exp. Immunol. 149:480.
  14. Joosten, L.A.B. et al. (2006) Proc. Natl. Acad. Sci. USA 103:3298.
  15. Nishida, A. et al. (2009) J. Biol. Chem. 284:17868.
  16. Rasool, S.T. et al. (2008) Immunol. Lett. 117:161.
  17. Nold, M.F. et al. (2008) J. Immunol. 181:557.
Long Name
Interleukin 32
Entrez Gene IDs
9235 (Human)
Alternate Names
IL32; IL-32; IL-32alpha; IL-32beta; interleukin 32; interleukin-32 theta; interleukin-32; natural killer cell transcript 4; Natural killer cells protein 4; NK4; NK4IL-32delta; TAIF; TAIFa; TAIFb; TAIFc; TAIFd; TAIFIL-32gamma; Tumor necrosis factor alpha-inducing factor

Product Datasheets

You must select a language.

x
Product Datasheet
COA
SDS

Citations for Human IL-32 Antibody

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

18 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. The pro-tumorigenic cytokine IL-32 has a high turnover in multiple myeloma cells due to proteolysis regulated by oxygen-sensing cysteine dioxygenase and deubiquitinating enzymes
    Authors: Martin Kastnes, Kristin Roseth Aass, Siri Anshushaug Bouma, Charlotte Årseth, Muhammad Zahoor, Mariia Yurchenko et al.
    Frontiers in Oncology
  2. Interplay between thyroid cancer cells and macrophages: effects on IL-32 mediated cell death and thyroid cancer cell migration
    Authors: Yvette J. E. Sloot, Katrin Rabold, Thomas Ulas, Dennis M. De Graaf, Bas Heinhuis, Kristian Händler et al.
    Cell Oncol (Dordr)
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  3. β-Glucan-Induced Trained Immunity Protects against Leishmania braziliensis Infection: a Crucial Role for IL-32
    Authors: JC Dos Santos, AM Barroso de, MV Teodoro Si, B Cirovic, LCJ de Bree, MSMA Damen, SJCFM Moorlag, RS Gomes, MM Helsen, M Oosting, ST Keating, A Schlitzer, MG Netea, F Ribeiro-Di, LAB Joosten
    Cell Rep, 2019-09-03;28(10):2659-2672.e6.
    Species: Transgenic Mouse
    Sample Types: Whole Tissue
    Applications: IHC-P
  4. Genetic variant in IL-32 is associated with the ex vivo cytokine production of anti-TNF treated PBMCs from rheumatoid arthritis patients
    Authors: MSMA Damen, K Schraa, L Tweehuysen, AA den Broede, MG Netea, CD Popa, LAB Joosten
    Sci Rep, 2018-09-19;8(1):14050.
    Species: Human
    Sample Types: Cell Culture Supernates
  5. Allele-specific long-distance regulation dictates IL-32 isoform switching and mediates susceptibility to HIV-1
    Authors: RJ Palstra, E de Crignis, MD Röling, T van Staver, TW Kan, W van Ijcken, YM Mueller, PD Katsikis, T Mahmoudi
    Sci Adv, 2018-02-21;4(2):e1701729.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  6. Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss
    Authors: Muhammad Zahoor, Marita Westhrin, Kristin Roseth Aass, Siv Helen Moen, Kristine Misund, Katarzyna Maria Psonka-Antonczyk et al.
    Blood Advances
    Species: Human
    Sample Types: Bone Marrow
    Applications: Western Blot
  7. Interleukin (IL)-32beta-mediated CCAAT/enhancer-binding protein alpha (C/EBPalpha) phosphorylation by protein kinase Cdelta (PKCdelta) abrogates the inhibitory effect of C/EBPalpha on IL-10 production.
    Authors: Kang J, Park Y, Kim M, Lee D, Bak Y, Ham S, Park S, Hong J, Yoon D
    J Biol Chem, 2013-06-30;288(33):23650-8.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Immunoprecipitation
  8. Role of interleukin-32 in Helicobacter pylori-induced gastric inflammation.
    Authors: Sakitani K, Hirata Y, Hayakawa Y, Serizawa T, Nakata W, Takahashi R, Kinoshita H, Sakamoto K, Nakagawa H, Akanuma M, Yoshida H, Maeda S, Koike K
    Infect Immun, 2012-08-13;80(11):3795-803.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  9. Inhibition of IL-32 activation by alpha-1 antitrypsin suppresses alloreactivity and increases survival in an allogeneic murine marrow transplantation model.
    Authors: Marcondes AM, Li X, Tabellini L, Bartenstein M, Kabacka J, Sale GE, Hansen JA, Dinarello CA, Deeg HJ
    Blood, 2011-09-06;118(18):5031-9.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  10. Inflammation-dependent secretion and splicing of IL-32{gamma} in rheumatoid arthritis.
    Authors: Heinhuis B, Koenders MI, van de Loo FA, Netea MG, van den Berg WB, Joosten LA
    Proc. Natl. Acad. Sci. U.S.A., 2011-03-07;108(12):4962-7.
    Species: Human
    Sample Types: Cell Culture Supernates
    Applications: ELISA Development
  11. Protection from RNA and DNA viruses by IL-32.
    Authors: Zepp JA, Nold-Petry CA, Dinarello CA, Nold MF
    J. Immunol., 2011-02-23;186(7):4110-8.
    Species: Human
    Sample Types: Cell Culture Supernates
    Applications: Electrochemiluminescent Assay
  12. Native IL-32 is released from intestinal epithelial cells via a non-classical secretory pathway as a membrane-associated protein.
    Authors: Hasegawa H, Thomas HJ, Schooley K, Born TL
    Cytokine, 2011-01-01;53(1):74-83.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  13. Interleukin-32 expression in the pancreas.
    Authors: Nishida A, Andoh A, Inatomi O, Fujiyama Y
    J. Biol. Chem., 2009-04-21;284(26):17868-76.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC
  14. Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease.
    Authors: Shioya M, Nishida A, Yagi Y, Ogawa A, Tsujikawa T, Kim-Mitsuyama S, Takayanagi A, Shimizu N, Fujiyama Y, Andoh A
    Clin. Exp. Immunol., 2007-06-22;149(3):480-6.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC
  15. IL-32 is induced by activation of toll-like receptors in multiple myeloma cells
    Authors: Kristin Roseth Aass, Synne Stokke Tryggestad, Robin Mjelle, Martin H. Kastnes, Tonje Marie Vikene Nedal, Kristine Misund et al.
    Frontiers in Immunology
  16. Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss
    Authors: Muhammad Zahoor, Marita Westhrin, Kristin Roseth Aass, Siv Helen Moen, Kristine Misund, Katarzyna Maria Psonka-Antonczyk et al.
    Blood Advances
  17. Interplay between thyroid cancer cells and macrophages: effects on IL-32 mediated cell death and thyroid cancer cell migration
    Authors: Yvette J. E. Sloot, Katrin Rabold, Thomas Ulas, Dennis M. De Graaf, Bas Heinhuis, Kristian Händler et al.
    Cell Oncol (Dordr)
  18. Intracellular IL-32 regulates mitochondrial metabolism, proliferation, and differentiation of malignant plasma cells
    Authors: Kristin Roseth Aass, Robin Mjelle, Martin H. Kastnes, Synne S. Tryggestad, Luca M. van den Brink, Ingrid Aass Roseth et al.
    iScience

FAQs

No product specific FAQs exist for this product, however you may

View all Antibody FAQs
Loading...

Reviews for Human IL-32 Antibody

Average Rating: 1 (Based on 1 Review)

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
100%

Have you used Human IL-32 Antibody?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Human IL-32 Antibody
By Anonymous on 03/08/2019
Application: Immunocytochemistry/Immunofluorescence Sample Tested: Adult lung Species: Human

Did not work with human lung sections without retreival or with citrate retreival - IgG was used as control.
***Bio-Techne Response: Thank you for reviewing our product. We are sorry to hear that this antibody did not perform as expected. We have been in touch with the customer to resolve this issue according to our Product Guarantee and to the customer’s satisfaction.***

Immunocytochemistry/Immunofluorescence Human IL-32 Antibody AF3040